Tamargo, Ian A <br/><br/>
Novel GLP-1R/GIPR co-agonist "twincretin" is neuroprotective in cell and rodent models of mild traumatic brain injury.  [electronic resource] 

 -  Experimental neurology  Feb 2017 
 - 176-186 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1090-2430 
<br/><br/><label>Standard No.: </label>10.1016/j.expneurol.2016.11.005  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Body Temperature--drug effects<br/>Brain Injuries, Traumatic--complications<br/>CREB-Binding Protein--metabolism<br/>Cell Line, Tumor<br/>Cells, Cultured<br/>Disease Models, Animal<br/>Embryo, Mammalian<br/>Glucagon-Like Peptide 1--metabolism<br/>Glucagon-Like Peptide-1 Receptor--metabolism<br/>Humans<br/>Incretins--therapeutic use<br/>Male<br/>Maze Learning--drug effects<br/>Memory Disorders--etiology<br/>Mice<br/>Mice, Inbred ICR<br/>Neuroblastoma--pathology<br/>Neuroprotective Agents--therapeutic use<br/>Rats<br/>Rats, Sprague-Dawley<br/>Reactive Oxygen Species--metabolism<br/>Receptors, Gastrointestinal Hormone--agonists<br/>Recognition, Psychology--drug effects<br/>Signal Transduction--drug effects<br/>Glucagon-Like Peptide-1 Receptor Agonists